In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates

Fosfomycin disodium is a potential therapeutic option to manage difficult-to-treat infections, especially when combined with other antimicrobials. In this study, we evaluated the activity of fosfomycin in combination with meropenem or polymyxin B against contemporaneous KPC-2-producing K. pneumoniae...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Aghata Cardoso da Silva, Chikhani, Yohanna Carvalho dos Santos Aoun, Valiatti, Tiago Barcelos, Valêncio, André, Kurihara, Mariana Neri Lucas, Santos, Fernanda Fernandes, Minarini, Luciene Andrade da Rocha, Gales, Ana Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952190/
https://www.ncbi.nlm.nih.gov/pubmed/36830148
http://dx.doi.org/10.3390/antibiotics12020237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952190/
https://www.ncbi.nlm.nih.gov/pubmed/36830148
http://dx.doi.org/10.3390/antibiotics12020237

Ejemplares similares